Taproot Health, Five Cancer Centers Agree to Conduct Precision Oncology Master Trial, Share Data
by Barry
13 Jan
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
Mr. Galloway has spent over 40 years in the healthcare sector as a hospital operator, consultant, and a serial entrepreneur. He is a trusted advisor to many of the leading health systems in the US, known for his strategic, organizational, and operational thought leadership. He helps guide new innovative companies serving the healthcare market to generate the most value for their customers and their investors.
Currently, he is the Chief Strategy Officer and leads Business Development for Taproot Health. Prior to Taproot, he was the founder and CEO of Galloway Consulting, a boutique performance improvement company that worked with over 500 health systems over 20 years. Earlier in his career, he worked in healthcare IT for HBO & Company, in consulting for Booz Allen & Hamilton, and as a hospital operator.
Mick is President and acting Chief Technology Officer, guiding the operational and technology development of the Taproot Platform.
Mick has served in operations and technology senior leadership roles for startups, growth companies and large provider and payor organizations in healthcare. Prior roles include COO of HCMS Group, acquired by UPMC, and Chief Commercial Officer at Twin Health. At UPMC Workpartners, he led the Advocacy business unit which integrated big data analytics, clinical services and consulting services to help employers and payors improve value and lower cost.
Renee is an expert in building relationships between medical providers, patients, and research teams to improve health outcomes. Over the past decade, Renee has worked with a variety of stakeholders to improve healthcare literacy, bridge language gaps between providers and patients, and implement clinical trials within medical practices. She has successfully executed a longitudinal observational research study in both hospital systems and private clinics, conducted extensive protocol training, and led data collection oversight programs.
Renee received her medical degree from La Universidad de San Carlos de Guatemala in 2009. In addition to her work in the U.S., she is the Medical Director for a school in Guatemala where she oversees free access to medical and dental services for over 1000 children. Renee also leads recurring international medical missions and training campaigns to this region, further demonstrating her ability to direct complex medical initiatives.
At Taproot Health, Renee leads the implementation of the ROOT Study with an accessible, dynamic, and interactive approach.
Lori is an experienced program manager with over 11 years of experience in clinical trial work. In her career, she has worked as a clinical research coordinator, data manager, monitor, and program manager. Her progression within clinical research has given her the knowledge and skills to oversee complex trials and research teams, knowledge that will be invaluable to Taproot as we collect patient‐consented, real‐world data at the point of care for patients across the nation.
Lori received a Master of Science and Technology from The University of Utah. She has worked for several major institutions, including The University of Utah, The Huntsman Cancer Institute, and UC Berkley.
Guy is a seasoned leader in all aspects of healthcare information technology finance. He has served in many leadership roles overseeing areas such as licensing, merger and acquisitions, business modelling, cross-unit coordination, contracting, and audit. He has over two decades of experience being an integral team member contributing to the growth and success of large health care enterprises. He has been able to identify major opportunities and challenges within an organization and create effective solutions to ensure optimal performance and positively impact the bottom line.
“We are extremely lucky to have Guy join our team,” said Dane Dickson, M.D., Chief Executive Officer of Taproot Health. “As we continue to roll out Taproot Health’s vision of accelerating cancer research through the point of care collection of patient-consented, regulatory-grade, real-world data, using Taproot’s proprietary model, Guy’s financial acumen provides a wealth of experience to continue to propel our company.”
Prior to joining Taproot Health, Guy held significant leadership roles at UnitedHealth’s OptumInsight division. He most recently served as their Director of Finance, managing all financial and accounting aspects of that division.
Dan brings to Taproot Health extensive experience in innovative healthcare technologies and a philosophy that health-tech systems must first and foremost be focused on affordably improving patient lives and outcomes.
Prior to joining Taproot Health, Dan held significant leadership and technology roles in the U.S. Army, and at several high technology and healthcare technology companies, including UnitedHealth Group. Most recently, while with UnitedHealth Group’s OptumInsight and Optum360 divisions, Dan led the product engineering portfolios for various business units and led business operations for large healthcare technology-related business units. In his various roles he has formed and led international technical and operations groups across the U.S., India, the Philippines, Puerto Rico, and Europe, and focused upon delivering best-in-class healthcare technologies and services.
Dan has also led very large teams of technical professionals through the strategic technical direction and product development of multiple health-tech solution suites. Included among these are several large healthcare claim clearinghouses and related electronic data interchange (EDI) and healthcare claim clinical accuracy editing products; innovative anti-fraud and abusive billing pattern detection analytics software; and health insurance subrogation technology sets.
Additionally, Dan led a global software engineering workforce through the design, business transformation, and adoption of a company-wide Agile/Scrum product development regimen. He also led the M&A integration efforts for multiple acquisitions to include an Ambulatory EMR software and services company, a Health Information Exchange business, a high acuity setting EMR technology company, and a large Physician Medical Necessity Review services organization.
Dan is a graduate of The Citadel (The Military College of South Carolina) and holds a MS in Software Engineering. His military decorations and badges include multiple awards of the Meritorious Service Medal and Army Commendation Medal; several awards of the Army Achievement Medal; expeditionary and NATO medals; the Ranger tab, and Parachutist and Air Assault wings.
Dr. Dickson is a practicing medical oncologist with deep experience in clinical trial reporting, molecular medicine and data collection. He previously served as CEO of the Summarius Corporation, which developed a proprietary format for clinical trial reporting and was adopted by two pharmaceutical companies. He was also a scientific advisor for two Medicare Administrative Contractors, advising on technical merits and evidence strength of molecular testing. In addition, he served as the Director of Clinical Science at Palmetto GBA’s MolDX program where he worked with many stakeholders on the technical and clinical strength of molecular medicine testing and direction.
Currently, he is CEO and founder of Taproot Health, which uses novel scientific approaches and business models to collect clinico-panomic data needed to advance precision medicine. He is the Director of Precision Medicine Policy and Registries at the Knight Cancer Center at Oregon Health and Science University. He has also served in various service and leadership roles in the Idaho Society of Clinical Oncology (ISCO) and the American Society of Clinical Oncology (ASCO).